Literature DB >> 6833886

A microfluorometric method for the determination of free fatty acids in plasma.

J Miles, R Glasscock, J Aikens, J Gerich, M Haymond.   

Abstract

A rapid and precise microfluorometric method for the determination of free fatty acid concentrations in 2-5 microliters of plasma is described. The assay is performed directly on plasma, eliminating the need for extraction with organic solvents, and is based on the quantitation of AMP generated from the formation of acyl coenzyme A in the presence of ATP and acyl CoA synthetase. Because of the sensitivity of this assay, reagent quantities, and thus costs, are significantly reduced compared with previously described enzymatic spectrophotometric methods. In addition, the inclusion of fatty acid-free human serum albumin in the standards corrects the previously reported underestimate of plasma free fatty acids with enzymic methods.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833886

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  73 in total

1.  A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM.

Authors:  G Paolisso; P A Tataranni; J E Foley; C Bogardus; B V Howard; E Ravussin
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

2.  Effects of depletion exercise and light training on muscle glycogen supercompensation in men.

Authors:  Harold W Goforth; Didier Laurent; William K Prusaczyk; Kevin E Schneider; Kitt Falk Petersen; Gerald I Shulman
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-08-05       Impact factor: 4.310

3.  Post-exercise glucose uptake and glycogen synthesis in human muscle during oral or i.v. glucose intake.

Authors:  C S Blom
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

4.  Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.

Authors:  Kitt Falk Petersen; Sylvie Dufour; Jing Feng; Douglas Befroy; James Dziura; Chiara Dalla Man; Claudio Cobelli; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

5.  The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.

Authors:  Kitt Falk Petersen; Sylvie Dufour; David B Savage; Stefan Bilz; Gina Solomon; Shin Yonemitsu; Gary W Cline; Douglas Befroy; Laura Zemany; Barbara B Kahn; Xenophon Papademetris; Douglas L Rothman; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

6.  Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.

Authors:  M R Taskinen; C Bogardus; A Kennedy; B V Howard
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

7.  Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle.

Authors:  P Nuutila; M J Knuuti; O J Heinonen; U Ruotsalainen; M Teräs; J Bergman; O Solin; H Yki-Järvinen; L M Voipio-Pulkki; U Wegelius
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.

Authors:  G B Bolli; E Tsalikian; M W Haymond; P E Cryer; J E Gerich
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  Errors in measuring plasma free fatty acid concentrations with a popular enzymatic colorimetric kit.

Authors:  Yilin Song; Lianzhen Zhou; Michael D Jensen
Journal:  Clin Biochem       Date:  2019-01-29       Impact factor: 3.281

10.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

Authors:  L C Groop; R C Bonadonna; S DelPrato; K Ratheiser; K Zyck; E Ferrannini; R A DeFronzo
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.